QIAGEN launches first FDA-approved companion diagnostic using FGFR alterations to help guide the treatment of metastatic urothelial cancer

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of its novel therascreen® FGFR RGQ RT-PCR Kit (therascreen FGFR Kit) as a companion diagnostic to help guide the use of the newly approved FGFR kinase inhibitor, BALVERSA™ (erdafitinib), developed by Janssen Biotech, Inc. (Janssen). The test will aid in identifying patients Read more about QIAGEN launches first FDA-approved companion diagnostic using FGFR alterations to help guide the treatment of metastatic urothelial cancer[…]

Caledonia Mining Corporation Plc

Caledonia Mining Corporation Plc (“Caledonia” or the “Company” – https://www.commodity-tv.net/c/search_adv/?v=298787) today announces that its board of directors has declared a dividend of six and seven eighths United States cents (US$0.06875) on each of the Company’s common shares. The relevant dates relating to the dividend are as follows: Ex-dividend date: April 11, 2019 Record date: April Read more about Caledonia Mining Corporation Plc[…]

Meyer Burger announces record HJT cells with efficiencies over 24% at PV CellTech

At the PV CellTech conference in Penang, Malaysia from 12 – 13 March 2019, Meyer Burger CTO, Dr Gunter Erfurt, will speak to two leading technology topics – Heterojunction and Passivated Contacts.   Heterojunction – Meyer Burger’s flagship technology At PV CellTech 2019, international PV industry leaders will discuss key issues driving the development of Read more about Meyer Burger announces record HJT cells with efficiencies over 24% at PV CellTech[…]

X-Ray Technology for inspection of coffee in metalized packs

The business of Sesotec´s reference customer Khao Shong Group Co.,Ltd. is the coffee blending. Over the years, developed Khao Shong the perfect manufacture process to ensure the optimal flavour of the coffee. Committed to nature and to the efficient use of resources this customer also strives to achieve highest quality. He thus was able to Read more about X-Ray Technology for inspection of coffee in metalized packs[…]

SMA Energy Data Services at E-world – Energy Data in Real Time for the Intelligent Integration of Prosumers into Energy Grids and Markets

SMA Solar Technology AG (SMA) will be unveiling its range of SMA Energy Data Services at E-world in Essen, Germany, from February 5 to February 7, 2019. Based on real-time data from over 400,000 PV and battery systems with 1.5 million connected devices on the world’s largest platform for energy data, SMA offers unique services Read more about SMA Energy Data Services at E-world – Energy Data in Real Time for the Intelligent Integration of Prosumers into Energy Grids and Markets[…]

QIAGEN receives approval for EGFR test in lung cancer as companion diagnostic in Japan

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the therascreen® EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer’s VIZIMPRO® (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent non-small cell lung cancer. The therascreen® EGFR RGQ PCR Kit is Read more about QIAGEN receives approval for EGFR test in lung cancer as companion diagnostic in Japan[…]

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer in clinical interpretation services for complex genomic data. The addition of N-of-One will enable QIAGEN to significantly expand its decision-support solutions while offering a broader range Read more about QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support[…]

QIAGEN to develop QuantiFERON-TB Access as a new test for low-resource, high-burden regions in global fight against TB

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to develop a proprietary new version of a QuantiFERON®-based tuberculosis (TB) test dedicated and tailored to the needs of low-resource regions with a high disease burden of TB. The new testing solution, QuantiFERON®-TB Access (QFT® Access), is designed to pair ultrasensitive digital detection of Read more about QIAGEN to develop QuantiFERON-TB Access as a new test for low-resource, high-burden regions in global fight against TB[…]

EnWave Receives Purchase Order for Third 120kW REVTM Machine from Milne Fruit Products

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" – http://www.commodity-tv.net/c/search_adv/?v=297852) announced today that it has signed an Equipment Purchase Agreement (the “EPA”) with Milne Fruit Products d.b.a. Milne MicroDried Inc. (“Milne”)  to provide Milne with its third 120kW Radiant Energy Vacuum (“REV™”) machine for the production of an extensive portfolio of dried vegetable and Read more about EnWave Receives Purchase Order for Third 120kW REVTM Machine from Milne Fruit Products[…]

EnWave Announces Fourth Quarter and 2018 Annual Consolidated Financial Results

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" – http://www.commodity-tv.net/c/search_adv/?v=297852) today reported the Company’s consolidated financial results for the fourth quarter and year-ended September 30,  2018. EnWave’s annual and interim consolidated financial statements and MD&As are available on SEDAR at www.sedar.com and on the Company’s website www.enwave.net. Key Financial Highlights for 2018 and Q4 Read more about EnWave Announces Fourth Quarter and 2018 Annual Consolidated Financial Results[…]